top of page
GrayMatters Health Header image

 24 May 2022

Feasibility and utility of amygdala neurofeedback

​

/ Goldway N, Jalon I, Keynan JN, Hellrung L, Horstmann A, Paret C, Hendler T.Neurosci Biobehav Rev. 2022 Jul;138:104694.

​

A review of research studies that tested the effects of amygdala-neurofeedback (using either fMRI or amygdala-EFP) on the ability to self-regulate the amygdala.


This is a meta-analysis of 33 studies, in which amygdala neurofeedback was accomplished either in an EEG setting measuring the amygdala-EFP signal, or in an fMRI setting measuring amygdala activity. Overall, amygdala neurofeedback resulted in (1) increased regulation (relative to baseline), (2) improved self-regulation following multiple training sessions, and (3) improved clinical symptoms following multiple training sessions.

 

The article further analyzes aspects of study design that contribute to neurofeedback efficacy. An additional re-analysis of fMRI studies further revealed that when the amygdala is down-regulated by neurofeedback, the activity reduction in the amygdala is associated with a reduction in activity of other brain regions including the insula, prefrontal cortex, and parahippocampal cortex.​

​

To read the full article in Neuroscience & Biobehavioral Reviews - https://www.sciencedirect.com/science/article/abs/pii/S014976342200183X

GrayMatters Health logo

© 2025 GrayMatters Health. All Rights Reserved.

Disclaimer: The information on this website is not intended to be a substitute for professional medical advice. Always discuss treatment options and treatment outcomes with your physician or other qualified mental health provider.​

  • LinkedIn
  • Youtube
bottom of page